StockData
Werewolf Therapeutics, Inc. logo

Werewolf Therapeutics, Inc. (HOWL) stock

HOWLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.95−0.04 (-3.97%)

Close on Nov 20, 2026Market cap $46.00MP/E –Yield –

Earnings

Werewolf Therapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Nov 3, 2026
Q3 FY2026 · estimated, before the open
Revenue, Q2 FY2026
$21.00M
EPS, Q2 FY2026
$0.08
-$0.40 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Werewolf Therapeutics's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q3 FY2026ended Sep 30, 2026Nov 3, 2026Expected––––
Q2 FY2026ended Jun 30, 2026Jul 31, 2026before the open$21.00M–$0.08Release
Q1 FY2026ended Mar 31, 2026May 7, 2026during market hours––-$0.28Release
Q4 FY2025ended Dec 31, 2025Mar 27, 2026before the open––-$0.20Release
Q3 FY2025ended Sep 30, 2025Nov 4, 2025before the open––-$0.36Release
Q2 FY2025ended Jun 30, 2025Aug 14, 2025before the open––-$0.40Release
Q1 FY2025ended Mar 31, 2025May 8, 2025before the open–––Release
Q4 FY2024ended Dec 31, 2024Mar 11, 2025before the open––-$0.46Release
Q3 FY2024ended Sep 30, 2024Nov 7, 2024before the open––-$0.38Release
Q2 FY2024ended Jun 30, 2024Aug 8, 2024before the open$1.10M-86.4%-$0.43Release
Q1 FY2024ended Mar 31, 2024May 3, 2024before the open$700.00K-84.4%-$0.39Release
Q4 FY2023ended Dec 31, 2023Mar 7, 2024before the open$1.50M-79.5%-$0.33Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Werewolf Therapeutics has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Werewolf Therapeutics puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Werewolf Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K

  1. Update
  2. Update
  3. Update
  4. Results
  5. Results
  6. Results
  7. News
  8. News
  9. Results
  10. Results
  11. Results
  12. Results
  13. Results
  14. Results
  15. Update

See a number that looks wrong?